Doxazosin Mesylate
Pricing Report NDC 59762-2340-6

Latest NADAC: $0.10210 per EA · Effective Feb 21, 2024 · Est. package price $10.21 (100 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Doxazosin Mesylate (NDC 59762-2340-6) is $0.10210 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 21, 2024.

As a provided by Mylan Pharmaceuticals Inc., this medication is distributed in a 100 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.10210
Per EA

Effective Date
Feb 21, 2024
Billable Units
100 EA
Estimated Package Price
$10.21
Data Status
As of Feb 21, 2024
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2014, the NADAC wholesale price for (NDC ) has moved within a range of $0.08126 to $0.56470 per EA. Over this 9 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0813 - $0.5647
Market Volatility
594.93% Variance
Latest Trend
5.66%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Feb 21, 2024 $0.10210 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 17, 2024 $0.10822 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 20, 2023 $0.11715 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 22, 2023 $0.10608 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 18, 2023 $0.10556 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 20, 2023 $0.09672 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 23, 2023 $0.10762 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 19, 2023 $0.11459 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 21, 2023 $0.10127 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 17, 2023 $0.10414 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 19, 2023 $0.10532 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 22, 2023 $0.11069 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026